Cargando…

High‐mobility group box‐1 contributes tumor angiogenesis under interleukin‐8 mediation during gastric cancer progression

Many soluble factors are involved in tumor angiogenesis. Thus, it is valuable to identify novel soluble factors for effective control of tumor angiogenesis in gastric cancer (GC). We investigated the role of extracellular high‐mobility group box‐1 (HMGB1) and its associated soluble factors in the tu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chung, Hye Won, Lim, Jong‐Baeck
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543560/ https://www.ncbi.nlm.nih.gov/pubmed/28574630 http://dx.doi.org/10.1111/cas.13288

Ejemplares similares

Serum high mobility group box-1 (HMGB1) is closely associated with the clinical and pathologic features of gastric cancer
por: Chung, Hye Won, et al.
Publicado: (2009)

A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer
por: Chung, Hye Won, et al.
Publicado: (2019)

Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma
por: WANG, WEI, et al.
Publicado: (2013)

Clinical significance of serum thymus and activation-regulated chemokine in gastric cancer: Potential as a serum biomarker
por: Lim, Jong-Baeck, et al.
Publicado: (2014)

Clinical significance of elevated serum soluble CD40 ligand levels as a diagnostic and prognostic tumor marker for pancreatic ductal adenocarcinoma
por: Chung, Hye Won, et al.
Publicado: (2014)

Role of Glycated High Mobility Group Box-1 in Gastric Cancer
por: Kishi, Shingo, et al.
Publicado: (2021)

Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma
por: Zhu, Lingyin, et al.
Publicado: (2015)

Dysregulation of tristetraprolin and human antigen R promotes gastric cancer progressions partly by upregulation of the high-mobility group box 1
por: Wang, Hao, et al.
Publicado: (2018)

Overexpression of high mobility group box 1 contributes to progressive clinicopathological features and poor prognosis of human bladder urothelial carcinoma
por: Huang, Changkun, et al.
Publicado: (2018)

Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice
por: Kitadai, Y, et al.
Publicado: (1999)

High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
por: García-Arnandis, Isabel, et al.
Publicado: (2010)

Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer
por: Takaki, Wataru, et al.
Publicado: (2022)

High mobility group box 2 modulates the progression of osteosarcoma and is related with poor prognosis
por: Yang, Shicong, et al.
Publicado: (2020)

Contributing Role of High Mobility Group Box 1 Signaling in Oral Cancer Development and Therapy
por: Plemmenos, Grigorios, et al.
Publicado: (2023)

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma
Publicado: (1994)

High-Mobility Group Box-1-Induced Angiogenesis After Indirect Bypass Surgery in a Chronic Cerebral Hypoperfusion Model
por: Nishihiro, Shingo, et al.
Publicado: (2019)

Identification of novel epitopes from human papillomavirus type 18 E7 that can sensitize PBMCs of multiple HLA class I against human cervical cancer
por: Kim, Sunghoon, et al.
Publicado: (2014)

Identificaiton of Novel Immunogenic Human Papillomavirus Type 16 E7-Specific Epitopes Restricted to HLA-A(*)33;03 for Cervical Cancer Immunotherapy
por: Kim, Sunghoon, et al.
Publicado: (2017)

Etanercept ameliorates psoriasis progression through regulating high mobility group box 1 pathway
por: Li, Shu, et al.
Publicado: (2023)

High Mobility Group Box 1 Contributes to the Acute Rejection of Liver Allografts by Activating Dendritic Cells
por: Chen, Yi, et al.
Publicado: (2021)

Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
por: Gong, Zhenqiang, et al.
Publicado: (2018)

High-mobility group box 1: role in ARDS
por: Ishizaka, A, et al.
Publicado: (2005)

High‐Mobility Group Box‐1 and Liver Disease
por: Gaskell, Harriet, et al.
Publicado: (2018)

High mobility group box 1 in diabetic nephropathy
por: Shi, Haitao, et al.
Publicado: (2017)

High Mobility Group Box 1 in Human Cancer
por: Rapoport, Bernardo L., et al.
Publicado: (2020)

PTPRD-inactivation-induced CXCL8 promotes angiogenesis and metastasis in gastric cancer and is inhibited by metformin
por: Bae, Won Jung, et al.
Publicado: (2019)

The molecular mechanisms of Aloin induce gastric cancer cells apoptosis by targeting High Mobility Group Box 1
por: Tao, Hong, et al.
Publicado: (2019)

High mobility group box 1 contributes to wound healing induced by inhibition of dipeptidylpeptidase 4 in cultured keratinocytes
por: Sinagra, Tiziana, et al.
Publicado: (2015)

The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1
por: Li, Huifen, et al.
Publicado: (2015)

Loss of zinc‐finger protein 143 contributes to tumour progression by interleukin‐8‐CXCR axis in colon cancer
por: Verma, Vikas, et al.
Publicado: (2019)

Mitochondrial Translocation of High Mobility Group Box 1 Facilitates LIM Kinase 2-Mediated Programmed Necrotic Neuronal Death
por: Hyun, Hye-Won, et al.
Publicado: (2016)

Propofol inhibits the release of interleukin-6, 8 and tumor necrosis factor-α correlating with high-mobility group box 1 expression in lipopolysaccharides-stimulated RAW 264.7 cells
por: Jia, Jie, et al.
Publicado: (2017)

High mobility group box 1: as a 'testament' mediator
por: Maruyama, I, et al.
Publicado: (2005)

The Role of High Mobility Group Box 1 in Innate Immunity
por: Lee, Shin-Ae, et al.
Publicado: (2014)

High Mobility Group Box Protein-1 in Wound Repair
por: Ranzato, Elia, et al.
Publicado: (2012)

High-Mobility Group Box 1 in Dry Eye Inflammation
por: Lema, Carolina, et al.
Publicado: (2018)

The Role of High Mobility Group Box 1 in Ischemic Stroke
por: Ye, Yingze, et al.
Publicado: (2019)

Role of High-Mobility Group Box-1 in Liver Pathogenesis
por: Khambu, Bilon, et al.
Publicado: (2019)

High Mobility Group Box 1 Protein in Cerebral Thromboemboli
por: Essig, Fabian, et al.
Publicado: (2021)

Urinary and serum levels of high mobility group box 1
por: Nakamura, Toshihiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7sgb1n5j2i6a7otu1vg4chg5oo